Macrophage/microglia polarization for the treatment of diabetic retinopathy.

Yujia Yao, Jiajun Li, Yunfan Zhou, Suyu Wang, Ziran Zhang, Qin Jiang, Keran Li

Journal: Frontiers in endocrinology 2023;14():1276225

PMID: 37842315

Abstract

Macrophages/microglia are immune system defense and homeostatic cells that develop from bone marrow progenitor cells. According to the different phenotypes and immune responses of macrophages (Th1 and Th2), the two primary categories of polarized macrophages/microglia are those conventionally activated (M1) and alternatively activated (M2). Macrophage/microglial polarization is a key regulating factor in the development of inflammatory disorders, cancers, metabolic disturbances, and neural degeneration. Macrophage/microglial polarization is involved in inflammation, oxidative stress, pathological angiogenesis, and tissue healing processes in ocular diseases, particularly in diabetic retinopathy (DR). The functional phenotypes of macrophages/microglia affect disease progression and prognosis, and thus regulate the polarization or functional phenotype of microglia at different DR stages, which may offer new concepts for individualized therapy of DR. This review summarizes the involvement of macrophage/microglia polarization in physiological situations and in the pathological process of DR, and discusses the promising role of polarization in personalized treatment of DR.

Copyright © 2023 Yao, Li, Zhou, Wang, Zhang, Jiang and Li.

Address: Department of Ophthalmology, The Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.; The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.